HOME > Nephrology > Normalization of Hemoglobin Level in Patients With Chronic Kidney Disease and Anemia
Normalization of Hemoglobin Level in Patients With Chronic Kidney Disease and Anemia
Patients treated with an ESA and dosed to a target hemoglobin of 13.5 g-dL are at a significantly increased risk for serious and life-threatening cardiovascular complications.
Medscape Nephrology
